Compounded Medication – Prescription Only

This product is a compounded injectable formulation containing sermorelin acetate and is dispensed only pursuant to a valid prescription issued by a licensed healthcare provider. Sermorelin acetate is a synthetic peptide consisting of a fragment of the naturally occurring growth hormone–releasing hormone (GHRH). In compounding practice, sermorelin formulations may be prescribed when a provider determines that individualized formulation, concentration, or dosing considerations are clinically appropriate for a specific patient. This product is not available for self-selection and may only be dispensed following provider authorization.

Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). The FDA does not evaluate compounded formulations for safety, effectiveness, or manufacturing quality. Compounding is performed by a state-licensed pharmacy pursuant to a patient-specific prescription. This page provides general, non-therapeutic information for educational and compliance purposes only. It does not describe intended use, therapeutic benefit, endocrine effects, growth hormone outcomes, or expected clinical results.

General Scientific Information (Non-Therapeutic)

Sermorelin acetate has been examined in scientific and laboratory settings for its amino-acid structure and its interaction with pituitary signaling pathways involved in peptide secretion. Descriptions of molecular structure or biochemical interactions are provided solely for general scientific context. No claims are made regarding safety, effectiveness, hormone production, anti-aging effects, body composition, sleep, recovery, or suitability for any particular condition.

Contraindications

Sermorelin should not be used in individuals who have a known hypersensitivity or allergy to sermorelin or any component of the compounded formulation; have experienced prior adverse reactions to peptide-based injections; have active malignancy involving the pituitary or hypothalamus; or have other conditions in which peptide hormone–related therapy is contraindicated as determined by the prescribing healthcare provider. Use in pregnant or breastfeeding individuals should occur only if a licensed healthcare provider determines that potential risks and benefits have been carefully evaluated.

Warnings and Precautions

Peptide-based injectable formulations may produce local or systemic reactions. Injectable administration should be performed only as prescribed and supervised by a licensed medical provider. Patients should inform their healthcare provider of all medical conditions, medications, and supplements prior to use. This product should not be used outside provider-directed protocols.

Potential Side Effects

Reported side effects associated with injectable peptide formulations may include injection site reactions such as redness, swelling, irritation, or discomfort; headache; dizziness; flushing; nausea; or fatigue. Serious adverse reactions are uncommon but may occur. Patients should seek medical attention if they experience signs of a severe allergic reaction or unexpected systemic symptoms.